BAM Logo

Sanger DNA Sequencing

EPTIS factsheet 794282 | Last revision 2020-10-23 | URL: https://www.eptis.bam.de/pts794282 https://www.eptis.bam.de/pts794282

PT provider
Based in Australia
Language(s) English
Remarks This is a technical module to assess laboratory performance in Sanger sequencing. There are two components in this module; (i) Technical component - participants are required to submit raw sequencing data files for analysis, (ii) Diagnostic component - participants are required to report gene variants detected.
Product groups Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
PCR products and sequencing primers PCR product clean-up -
Post-sequencing clean-up -
Sanger sequencing -
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by
Fees and frequency
Participation fee Yes
Regularly operated Yes (2 cases (4 sequencing reactions) per survey/1 survey per year)
Year of first operation
Contact details of the PT provider
Provider Contact person
Suite 201/8 Herbert Street
St Leonards, 2065

Phone: (61 2) 9045 6000
Fax: (61 2) 9356 2003
Web: https://www.rcpaqap.com.au/ https://www.rcpaqap.com.au/
Mr Rhys Judd
Phone: (61 2) 9045 6000
Fax: (61 2) 9356 2003
Email: rhys.judd@rcpaqap.com.au rhys.judd@rcpaqap.com.au
If you find any mistakes please contact the responsible EPTIS coordinator in Australia, Ms Luminita Antin. Ms Luminita Antin.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5